Concepedia

Author

Mark Seungwook Kim

The University of Texas MD Anderson Cancer Center

Also Known As

Mark Seungwook Kim

34

Publications

158

Citations

5

H-Index

0

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterSun Yat-sen UniversityActelion (Switzerland)Sixth Affiliated Hospital of Sun Yat-sen University
MS

About

Mark Seungwook Kim is an author at The University of Texas MD Anderson Cancer Center.

Mark Seungwook Kim

×

4

Publications

149

Citations

4

H-Index

YearCitations

Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

Sun-Jin Kim, Ho Jeong Lee, Mark Seungwook Kim,

Clinical Cancer Research

2015

60

Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel

Ho Jeong Lee, Masaki Hanibuchi, Sun-Jin Kim,

Neuro-Oncology

2016

56

GnRH-R–Targeted Lytic Peptide Sensitizes <i>BRCA</i> Wild-type Ovarian Cancer to PARP Inhibition

Shaolin Ma, Sunila Pradeep, Alejandro Villar‐Prados,

Molecular Cancer Therapeutics

2019

17

Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian Cancer

Mark Seungwook Kim, Shaolin Ma, Anca Chelariu-Raicu,

Molecular Cancer Therapeutics

2020

16

Page 1